Beta-Tocopherol: A Comprehensive Reference
1. Identity: Chemical Name, Structure, and Classification
Beta-tocopherol (β-tocopherol) is one of the eight naturally occurring compounds collectively referred to as vitamin E. Vitamin E exists in eight different forms: four tocopherols and four tocotrienols. Both the tocopherols and tocotrienols occur in α (alpha), β (beta), γ (gamma), and δ (delta) forms, determined by the number and position of methyl groups on the chromanol ring.
Beta-tocopherol is chemically designated as 5,8-dimethyltocol, distinguishing it from alpha-tocopherol (5,7,8-trimethyltocol), gamma-tocopherol (7,8-dimethyltocol), and delta-tocopherol (8-methyltocol). The molecular formula of beta-tocopherol is C₂₈H₄₈O₂, with a molecular weight of approximately 416.68 g/mol, and it carries the CAS Registry Number 148-03-8.
The chromanol ring of RRR-beta-tocopherol is methylated at positions 5 and 8, meaning it bears two methyl substituents rather than the three found on alpha-tocopherol. Chemically, all four tocopherols are methyl derivatives of tocol [2-methyl-2-(4′,8′,12′-trimethyltridecyl)-6-chromanol].
Structurally, tocopherols are characterized by a chromanol ring attached to a long hydrophobic phytyl tail, making them amphipathic molecules. This allows tocopherols to embed within biological membranes, where they stabilize lipid bilayers and prevent lipid peroxidation.
Tocopherols are primarily synthesized only by plants and certain other photosynthetic organisms, including cyanobacteria. As a result, mammalian dietary tocopherols are obtained almost exclusively from these sources.
2. Natural Sources and Distribution
All four members of the tocopherol series and the four members of the tocotrienol series are naturally present, though in varying amounts, in a wide range of foods. However, beta-tocopherol is among the least abundant of the four tocopherols in the food supply. Beta-tocopherol and delta-tocopherol are found in lower levels in foods compared to alpha- and gamma-tocopherol.
Alpha-tocopherol is found mostly in the chloroplasts of plant cells, whereas beta-, gamma-, and delta-tocopherols are commonly found outside these organelles.
Tocopherols are widely distributed in organic substances, occurring in highest concentrations in cereal grain oils, principally in wheat and corn oils, and also in barley and rye. They are also found in vegetable oils such as safflower, soybean, peanut, cottonseed, linseed, sunflower, rapeseed, and palm.
Wheat and its processing fractions represent a particularly well-characterized botanical source. Cereals are rich sources of tocols, with the highest levels being in barley and soft wheats. Most of the tocopherols (over 90% of all tocols) are located in the germ (~25 mg vitamin E/100 g in wheat), but significant concentrations of tocopherols are also present in wheat bran.
Studies examining commercial wheat milling streams have found that the germ fraction has the highest content of tocopherols, and the content of alpha-tocopherol (195.2 µg/g) was 16 times higher (on average) than in any other fraction. The content of tocopherols and tocotrienols, collectively known as vitamin E (tocols), was determined in fractions of roller-milled wheat grains. The results showed that vitamin E components are present in all major flour fractions of wheat, but that the vitamin E content and composition differed significantly between fractions.
Plant tissues vary considerably in total tocopherol content and tocopherol composition, with alpha-tocopherol the predominant tocopherol species found in green, photosynthetic plant tissues. Beta-tocopherol is thus typically found at much lower concentrations than alpha-tocopherol in most vegetable tissues and seed oils.
Common Forms and Preparations
Beta-tocopherol is not commonly manufactured or sold as an isolated compound. In commercial practice, it appears as a minor constituent within mixed tocopherol preparations derived from natural vegetable oil distillates. Concentrates of mixed tocopherol homologues including beta-, delta-, and gamma-tocopherols, along with tocotrienols, can be derived from natural plant sources. Industrial separation of beta-, delta-, and gamma-homologues in high purity from alpha-tocopherol is technically achievable through chromatographic methods.
Alpha-tocopherol in dietary supplements and fortified foods is often esterified to prolong its shelf life while protecting its antioxidant properties. The same approach — esterification of the hydroxyl group on the chromanol ring — is technically applicable to beta-tocopherol, although such isolated preparations are primarily encountered in research settings rather than commercial supplementation.
Synthetic production of vitamin E usually yields about equal amounts of the eight possible isomers: RRR, RSS, RRS, RSR, SRR, SRS, SSR, and SSS. The natural form of beta-tocopherol is designated RRR-beta-tocopherol, indicating the stereochemistry at the three chiral centers in the phytyl side chain.
3. History of Discovery and Traditional / Historical Use
The history of beta-tocopherol is inseparable from the broader scientific discovery of vitamin E, and has no documented tradition of isolated use in pre-modern herbal or medical systems. Unlike many botanical preparations with centuries of empirical use, beta-tocopherol was identified entirely within the framework of twentieth-century nutritional biochemistry.
Discovery of Vitamin E and Isolation of Beta-Tocopherol
The 100th anniversary of the discovery of vitamin E in 1922 was marked in recent years. That discovery was made by Herbert McLean Evans, an embryologist and endocrinologist, and his co-worker Kathrine Julia Scott Bishop, a medical physician and trained anatomist, while working at Berkeley University in California, USA.
The two scientists observed that female rats fed on a purified diet had good growth and development and stayed healthy, but could not reproduce, as the embryos died and were resorbed after some 10 days of gravidity. However, when the semi-synthetic diet was supplemented with fresh green leaves of lettuce or dried alfalfa meal, a sudden restoration of fertility in previously sterile rats could be observed.
Because the vitamin activity was first identified in 1936 from a dietary fertility factor in rats, it was named tocopherol, from Greek τόκος tókos 'birth' and φέρειν phérein 'to bear or carry', that is 'to carry a pregnancy', with the ending -ol signifying its status as a chemical alcohol.
In 1936, Evans and his co-workers isolated two compounds with vitamin E activity from wheat germ oil, for which they proposed the names α-tocopherol and β-tocopherol. Soon afterward, a third active factor, γ-tocopherol, was found in cottonseed oil by Evans' working group, and in 1947, a fourth tocopherol, named δ-tocopherol, was isolated from soybean oil.
Vitamin E was discovered in 1922 by Herbert McLean Evans and Katharine Scott Bishop and first isolated in a pure form by Evans and Gladys Anderson Emerson in 1935 at the University of California, Berkeley. The early history of vitamin E from its discovery by Herbert M. Evans and Katharine J. S. Bishop in 1922 up to its chemical synthesis by Paul Karrer and coworkers in 1938 and the development of the concept that vitamin E acts as an antioxidant in vivo are recalled.
Work in the 1930s revealed the chemical structure and the biological function of alpha-tocopherol. In the 1940s, Filer and others demonstrated that vitamin E protects tissue unsaturated fatty acids against oxidation. Research interest subsequently shifted predominantly to alpha-tocopherol, which demonstrated the greatest biological potency in standard bioassays.
Because beta-tocopherol occurs as a minor constituent of commonly consumed plant foods — particularly cereal grains and their oils — it has been part of the human diet throughout recorded history as a naturally co-occurring component of wheat germ, cereal brans, and vegetable oils. However, its presence as such was not recognized or intentionally exploited until the twentieth century. There is no documented traditional medicine system in which beta-tocopherol, as a distinct compound, was identified, named, or specifically utilized.
4. Key Constituents, Biochemistry, and Mechanisms of Action
Structure–Activity Relationship within the Tocopherol Family
All natural forms and synthetic stereoisomers of vitamin E exhibit to varying degrees the ability to inhibit lipid peroxidation as chain-breaking antioxidants. Antioxidant activities of tocols are greater in solution than in lipid membranes, but the rank order of antioxidant activities remains α > β ≈ γ > δ for both substrate presentations.
Alpha-tocopherol is approximately twice as efficient a radical quencher as gamma- and beta-tocopherol, and about 5 times better than delta-tocopherol in chemical measures of antioxidant activity. These findings, however, likely have little relevance to in vivo biological activity, as selective distribution and metabolism of dietary tocols heavily favor the retention of alpha-tocopherol in tissues.
Antioxidant (Chain-Breaking) Mechanism
Alpha-tocopherol is a fat-soluble antioxidant functioning within the glutathione peroxidase pathway, protecting cell membranes from oxidation by reacting with lipid radicals produced in the lipid peroxidation chain reaction. This removes the free radical intermediates and prevents the oxidation reaction from continuing. The oxidized tocopheroxyl radicals produced in this process may be recycled back to the active reduced form through reduction by other antioxidants, such as ascorbate, retinol, or ubiquinol.
Beta-tocopherol shares this fundamental chromanol ring mechanism. Kinetic studies have shown that a tocopherol can trap more than two mol of radicals — namely 2.3–2.9 mol — per mol of tocopherol, and can trap alkyl radicals as well as peroxy radicals. The difference between beta- and alpha-tocopherol in this regard is primarily quantitative, arising from the absence of the 7-methyl substituent in beta-tocopherol, which modestly reduces the electron density of the phenolic hydroxyl group.
Because it is fat-soluble, vitamin E is important for preventing oxidation of fats in places like cell membranes and mitochondria, as well as preventing the oxidation of low-density lipoproteins (LDLs) circulating in the blood.
Non-Antioxidant Mechanisms (Shared with Other Tocopherols)
Early investigators attributed most if not all of the biological activity of the tocopherols to their ability to act as antioxidants. More recently, however, other biological activities have been associated with tocopherols including the modulation of signal transduction, modulation of phospholipid metabolism, inhibition of protein kinase C, inhibition of phospholipase A, and inhibition of prostaglandin production.
More recent results include the influence of vitamin E on enzyme activities, signaling cascades, gene expression, and bio-membrane structure. The overall conclusion is that our knowledge of the vitamin's mechanism of action still remains fragmentary.
Relative Biopotency
The biological activities of the β-, γ-, and δ-isoforms of vitamin E are 0.5, 0.25, and 0.01, respectively, compared to α-tocopherol. This means that beta-tocopherol possesses approximately half the biological potency of alpha-tocopherol when assessed using the classical rat fetal resorption–gestation bioassay. With the exception of a 'generic' putative antioxidant activity in protecting biological membranes from peroxidation, in comparison to alpha-tocopherol, beta-, gamma-, and delta-tocopherol have very low (if any) biological activity in the fetal re-absorption test. Their relative efficiency ranges from zero to about 40% for beta-tocopherol, which is the only alternative form significantly active in this test.
Hepatic Metabolism and the Alpha-Tocopherol Transfer Protein
A critical determinant of why beta-tocopherol accumulates only at very low concentrations in human plasma and tissues — despite being present in foods — is the selectivity of the hepatic alpha-tocopherol transfer protein (α-TTP). After hepatic uptake, the alpha-tocopherol form of vitamin E is preferentially re-secreted into the circulation. Alpha-tocopherol transfer protein (α-TTP), a small cytoplasmic hepatic protein with differential affinity for various vitamin E forms, is responsible for the bio-discrimination process underlying the selective resecretion of alpha-tocopherol from the liver into plasma.
Alpha-TTP has ligand specificity and relative affinities towards different tocopherols (α- > β- > γ- > δ-tocopherol) in vitro. Beta-tocopherol is thus bound and re-secreted by α-TTP at a substantially lower efficiency than alpha-tocopherol. The plasma concentration of the other tocopherols and tocotrienols is usually below 2 μM because they are not efficiently retained by the liver, metabolized, and predominantly eliminated.
Vitamin E encompasses eight forms, including alpha, beta, gamma, and delta-tocopherol and alpha, beta, gamma, and delta-tocotrienol. However, only alpha-tocopherol is found in abundance and maintained well in human plasma. This observation directly reflects the discriminating action of α-TTP.
The hepatic α-tocopherol transfer protein (TTP) is required for optimal alpha-tocopherol bioavailability in humans; mutations in the human TTPA gene result in the heritable disorder ataxia with vitamin E deficiency (AVED).
Absorption
As with all fat-soluble vitamins, transport and absorption require intact fat digestion mechanisms. Fat metabolism involves both lingual and gastric lipases, bile salts, pancreatic enzymes, and intestinal absorption. Pancreatic enzymes break down tocopheryl-ester bonds. Chylomicrons then transport alpha-tocopherol through the lymphatics to the liver. Once broken down in the liver, tocopherol is released from the chylomicrons. Beta-tocopherol follows the same initial intestinal absorption pathway, but is subsequently discriminated against by α-TTP during the hepatic re-secretion step.
5. Scientific Evidence by Area of Use
It is essential to note at the outset that virtually all clinical trials examining vitamin E and health outcomes have used isolated alpha-tocopherol as the test compound, not beta-tocopherol. Most of the studies with vitamin E have been done with alpha-tocopherol, and stabilized forms of vitamin E are mainly derived from alpha-tocopherol. The following discussion covers the evidence primarily as it applies to the vitamin E class, with specific commentary on beta-tocopherol's contribution where sources permit.
5.1 Cardiovascular Disease
The use of alpha-tocopherol as a preventive antioxidant has been studied concerning cardiovascular disease, cancer, age-related macular degeneration, nonalcoholic fatty liver disease, and Alzheimer disease. The theory is that lipid oxidation plays a pivotal role in developing cardiovascular disease and that the use of antioxidants as adjunctive therapy is useful for prevention. However, studies of vitamin E in the prevention of cardiovascular disease have not proven beneficial, with inconsistent outcomes and inherent study limitations.
Population studies have suggested that people who consumed foods with more vitamin E, or who chose on their own to consume a vitamin E dietary supplement, had lower incidence of cardiovascular diseases, cancer, dementia, and other diseases. However, placebo-controlled clinical trials using alpha-tocopherol as a supplement, with daily amounts as high as 2,000 mg per day, could not always replicate these findings.
For years, it was thought that alpha-tocopherol only functioned as a scavenger of lipid peroxyl radicals, specifically oxidized low-density lipoprotein (oxLDL), thereby serving as a chief antioxidant for the prevention of atherosclerosis. In recent years, the many roles of alpha-tocopherol have been uncovered, including not only antioxidant functions, but also pro-oxidant, cell signaling, and gene regulatory functions.
Evidence strength for cardiovascular endpoints: Mixed and not conclusive. Observational data suggested benefit; randomized controlled trials (RCTs) of isolated alpha-tocopherol supplementation have not demonstrated consistent cardiovascular benefit. No specific RCTs have been conducted with isolated beta-tocopherol.
5.2 Cancer Prevention
Antioxidant use of vitamin E in the prevention of cancers has not been shown to be effective and may increase the risk of prostate cancer. In the SELECT trial, researchers studied selenium and vitamin E to see what role there was for supplementation in decreasing the incidence of prostate cancer. Participants were randomly assigned to either supplementation with selenium, vitamin E, both, or placebo.
The Alpha-Tocopherol, Beta-Carotene (ATBC) Cancer Prevention Study, often cited in this field, investigated alpha-tocopherol (not beta-tocopherol) in Finnish male smokers. The Alpha-Tocopherol, Beta-Carotene (ATBC) Cancer Prevention Study raised a flag of caution. Among 29,133 male smokers in Finland, ages 50 to 69 years, vitamin E ingested at 50 mg per day for 5 to 8 years was associated with certain outcomes.
Decades of clinical and preclinical studies have broadened our understanding of the antioxidant vitamin E and its utility in a number of chronic, oxidative stress-induced pathologies. The results of these studies have shown promising, albeit mixed, reviews on the efficacy of alpha-tocopherol in the prevention and treatment of heart disease, cancer, and Alzheimer's disease.
Evidence strength for cancer prevention: Weak and inconsistent for the vitamin E class (mostly alpha-tocopherol). No dedicated human clinical evidence exists for isolated beta-tocopherol in cancer prevention.
5.3 Neurological Disease and Cognitive Function
Vitamin E was first identified more than 90 years ago by Evans and Bishop as an essential dietary factor required by rats to maintain normal reproduction. Unlike the other three fat-soluble vitamins that have very specific molecular targets and actions, vitamin E lacks specific pathways or specific molecular targets that account for its requirement from the diet.
Vitamin E deficiency secondary to abetalipoproteinemia causes such problems as poor transmission of nerve impulses, muscle weakness, and retinal degeneration that leads to blindness.
As it became clear that vitamins A and D act through cognate nuclear hormone receptors to regulate vitamin-responsive gene expression, investigators sought, without success, to identify similar activities for vitamin E. These investigations simply led back to the same understanding of vitamin E obtained from studies carried out between the 1930s and the 1980s, that vitamin E acts as a fat-soluble antioxidant.
Evidence strength for neurological endpoints: Preliminary. The role of vitamin E in neurological health is established in the context of deficiency states. No specific human clinical trials have examined beta-tocopherol in isolation for neurological outcomes.
5.4 Immune Function
Vitamin E also plays a small role in cell signaling, affecting the expression of some immune cells. Among the other roles of vitamin E in the body, it also plays a significant role in immune function. A recent meta-analysis suggested reduced C-reactive protein and IL-6 were associated with alpha-tocopherol.
Evidence strength for immune function: Preliminary for the alpha-tocopherol form; not specifically studied for isolated beta-tocopherol in human trials.
5.5 Antioxidant Activity and Lipid Peroxidation
The most biologically active tocopherol is alpha-tocopherol, but beta-, gamma-, and delta-tocopherols and several stereoisomers may also have important biologic activity. These compounds act as antioxidants, which prevent lipid peroxidation of polyunsaturated fatty acids in cellular membranes.
The antioxidant activity of tocopherols is closely linked to membrane localization, where they scavenge lipid peroxyl radicals and prevent oxidative damage. The tocopheroxyl radical formed in this process can be regenerated in an antioxidant network by co-antioxidants such as vitamin C, preserving its antioxidant capacity.
Evidence strength for antioxidant function: Mechanistically well-established in vitro. Beta-tocopherol is a demonstrably effective chain-breaking antioxidant in chemical and cell-free systems. In vivo evidence for beta-tocopherol specifically is sparse because it does not accumulate significantly in plasma or tissues under normal dietary conditions.
6. Body Systems and Health Areas Associated with Beta-Tocopherol
- Cardiovascular system: As part of the vitamin E family, beta-tocopherol contributes to the prevention of LDL oxidation and lipid peroxidation in membranes. Vitamin E also has a role in circulation, being somewhat vasodilatory, inducing nitric oxide, and having some antithrombotic function.
- Nervous system: Vitamin E, primarily as alpha-tocopherol, is required for normal neurological function; beta-tocopherol shares the same structural determinants of membrane antioxidant activity relevant to this system.
- Immune system: Vitamin E plays a small role in cell signaling, affecting the expression of some immune cells.
- Reproductive system: Beta-tocopherol is the only non-alpha form with significant (though substantially lower) activity in the classical fetal resorption bioassay, with relative efficiency ranging from zero to about 40% of alpha-tocopherol.
- Skin / integument: The lipophilic nature of all tocopherols, including beta-tocopherol, allows them to protect skin cell membranes from oxidative damage, though dermatological research is focused almost entirely on alpha-tocopherol.
7. Dosage Forms and Reported Dosages
Beta-tocopherol is not commercially formulated as a standalone supplement and does not have established clinical dosing recommendations of its own. It appears in practice as a component of mixed tocopherol preparations derived from natural plant oil distillates.
The Daily Value (DV) for vitamin E is 15 mg for adults and children age 4 years and older, expressed as alpha-tocopherol equivalents. One mg vitamin E = 1 mg RRR-alpha-tocopherol = 2 mg all-rac-alpha-tocopherol. Beta-tocopherol's contribution to total vitamin E activity is calculated using a conversion factor reflecting its lower biopotency (approximately 0.5 relative to alpha-tocopherol).
Most vitamin-E-only supplements provide ≥67 mg (100 IU of natural vitamin E) of the nutrient. When mixed tocopherol supplements are used, beta-tocopherol is typically a minor fraction of the total, with alpha- and gamma-tocopherol predominating depending on the oil source.
In terms of reported research dosages for the vitamin E class (virtually all studies using alpha-tocopherol), doses across major clinical trials have ranged widely. Many adults take relatively large amounts of vitamin E (alpha-tocopherol 400 to 800 mg/day) for months to years without any apparent harm. A randomized, controlled, double-blind trial by Devaraj and colleagues found supplementation with 1,200 IU RRR alpha-tocopherol per day for two years in patients with cardiovascular disease to be safe.
No specific clinical dose–response studies have been conducted using isolated beta-tocopherol in human subjects.
8. Safety Considerations and Interactions
General Tolerability
As a member of the tocopherol family, beta-tocopherol shares the general safety profile of vitamin E compounds when consumed from food sources. The amounts of alpha-tocopherol, other tocopherols, and tocotrienols that are components of dietary vitamin E, when consumed from foods, do not appear to cause any interactions with drugs.
Upper Tolerable Intake Level
The upper limit for adults aged ≥19 years is 1,000 mg for any form of tocopherol. There is a risk of excess bleeding, particularly with doses greater than 1,000 mg daily or if an individual is also using a blood-thinning medication such as warfarin. For this reason, an upper limit for vitamin E has been set for adults 19 years and older of 1,000 mg daily (1,465 IU) of any form of tocopherol supplement.
The Institute of Medicine (IOM) arrived at this limit via animal data. The IOM reviewed all data relevant to vitamin E safety but did not identify a human NOAEL or LOAEL. Instead, it identified a LOAEL of 500 mg per kg per day from animal data and calculated a human UL by applying a composite uncertainty factor of 36. Assuming a body weight of 68.5 kg and rounding, the calculated UL is 1,000 mg per day for adults. Although the different chemical forms of vitamin E have different potencies (IU per mg) for beneficial effects, the IOM concluded that potency for potential adverse effects is not known to vary in an analogous manner, and therefore the IOM did not differentiate between all-rac and natural forms when applying this limit.
Anticoagulant and Antiplatelet Interactions
The use of vitamin E supplements may increase the risk of bleeding in individuals taking anticoagulant drugs (blood thinners), such as heparin and the vitamin K antagonist, warfarin (Coumadin); antiplatelet drugs, such as clopidogrel (Plavix), ticlopidine (Ticlid), tirofiban (Aggrastat), and dipyridamole (Aggrenox); and non-steroidal anti-inflammatory drugs (NSAIDs), including aspirin, ibuprofen, and others.
High doses of supplemental alpha-tocopherol may interfere with vitamin K absorption and thus increase the risk of bleeding. This interaction is especially important in individuals taking anticoagulant drugs.
Prescription medication interactions can occur when vitamin E levels are supplemented at levels greater than 300 mg daily. These common medications include aspirin, warfarin, cyclosporine, and tamoxifen.
Additionally, vitamin E decreases factor IX and platelet aggregation, further increasing the risk of coagulopathies.
Competition with Other Fat-Soluble Vitamins
Fat-soluble vitamins are all absorbed in the small intestines. Thus, it is reasonable to conclude that high-dose vitamin E supplementation could compete for absorption with other fat-soluble vitamins, leading to malabsorption or deficiency of vitamins A, D, and K.
High-Dose Alpha-Tocopherol Reducing Other Tocopherol Forms
An important pharmacokinetic consideration when taking large doses of supplemental alpha-tocopherol is that it can reduce circulating levels of other tocopherols. High intakes of alpha alone can reduce circulating gamma levels; mixed tocopherol formulations aim to mirror the diversity found in whole foods and may offer broader coverage. While this observation is specific to gamma-tocopherol, the same α-TTP–mediated competitive displacement mechanism is expected to apply to beta-tocopherol, which has a lower affinity for α-TTP than alpha-tocopherol does.
Adverse Effects at High Doses
Occasionally, muscle weakness, fatigue, nausea, and diarrhea occur. The most significant risk is bleeding; however, bleeding is uncommon unless the dose is greater than 1,000 mg/day or the patient takes oral coumarin or warfarin.
With vitamin E toxicity, other fat-soluble vitamins can be decreased. Some of the major drugs that vitamin E can interact with can cause complications with increased bleeding, hepatobiliary dysfunction, and malabsorption of other fat-soluble vitamins.
Analytical Challenges in Research
A practical complication in interpreting beta-tocopherol research is that co-elution of gamma- and beta-tocopherols may be a challenge in some chromatographic analytical methods, and therefore special attention should be paid to this potential problem. This analytical difficulty has contributed to the relative scarcity of beta-tocopherol–specific data in the scientific literature, as some earlier measurements may have inadvertently conflated gamma- and beta-tocopherol concentrations.
9. Summary of Evidence Quality
Beta-tocopherol occupies a structurally and biochemically intermediate position within the vitamin E family: it possesses demonstrable antioxidant activity (roughly equivalent to gamma-tocopherol in chemical assays), but is far less efficiently retained by the body than alpha-tocopherol due to its lower affinity for α-TTP. At present, an understanding of the differences in biological activity of the four tocopherols and their effect on the body remains limited. The near-complete absence of dedicated human clinical trials for beta-tocopherol means that its individual contributions to human health — beneficial or adverse — cannot be quantified from the current evidence base. All inferences about beta-tocopherol's biological role in humans must be extrapolated from: (1) its known in vitro antioxidant chemistry; (2) shared structural features with alpha-tocopherol; and (3) the extensive clinical literature on the vitamin E class, which studied alpha-tocopherol almost exclusively.
References
Go back